$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

$kacl Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224007254 Filed on February 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$226.4K	$413.9K
YoY Change		-45.3%	1855.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$158.3K	$226.4K	$413.9K
YoY Change	-25.95%	-45.3%	1855.08%
Operating Profit	-$158.3K	-$226.4K	-$413.9K
YoY Change	-25.95%	-45.3%	2579.6%
Interest Expense		$307.5K	$526.1K
YoY Change		-41.54%	228634.78%
% of Operating Profit
Other Income/Expense, Net	$204.8K	$307.5K	$526.1K
YoY Change	-11.29%	-41.54%	226660.78%
Pretax Income		$81.13K	$112.2K
YoY Change		-27.69%	-635.77%
Income Tax
% Of Pretax Income
Net Earnings	$46.54K	$81.13K	$112.2K
YoY Change	171.65%	-27.68%	-635.79%
Net Earnings / Revenue
Basic Earnings Per Share	$0.01	$0.02	$0.01
Diluted Earnings Per Share	$0.01	$0.02	$0.01
COMMON SHARES
Basic Shares Outstanding	3.684M shares	4.436M shares	8.921M shares
Diluted Shares Outstanding	3.684M shares	4.297M shares	8.408M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$390.00	$1.810K	$131.3K
YoY Change	-99.68%	-98.62%	-83.87%
Cash & Equivalents	$385.00	$1.809K	$131.3K
Short-Term Investments
Other Short-Term Assets	$16.72K	$14.85K	$60.12K
YoY Change	-89.12%	-75.3%	100.4%
Inventory
Prepaid Expenses			$60.12K
Receivables
Other Receivables
Total Short-Term Assets	$17.11K	$16.66K	$191.4K
YoY Change	-93.82%	-91.29%	-77.31%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$15.79M	$0.00	$21.82M
YoY Change	-29.54%	-100.0%	-72.3%
Other Assets		$15.44M	$2.600K
YoY Change		593659.23%
Total Long-Term Assets	$15.79M	$15.44M	$21.83M
YoY Change	-29.54%	-29.27%	-72.29%
TOTAL ASSETS
Total Short-Term Assets	$17.11K	$16.66K	$191.4K
Total Long-Term Assets	$15.79M	$15.44M	$21.83M
Total Assets	$15.81M	$15.45M	$22.02M
YoY Change	-30.33%	-29.81%	-72.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$309.7K	$244.0K	$222.0K
YoY Change	41.56%	9.93%	2063.45%
Accrued Expenses			$15.00K
YoY Change			-82.88%
Deferred Revenue
YoY Change
Short-Term Debt	$2.521M	$2.278M	$430.0K
YoY Change	131.29%	429.77%	514.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.831M	$2.522M	$667.0K
YoY Change	113.84%	278.13%	297.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.730M	$2.730M	$2.730M
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$2.730M	$2.730M	$2.730M
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.831M	$2.522M	$667.0K
Total Long-Term Liabilities	$2.730M	$2.730M	$2.730M
Total Liabilities	$5.561M	$5.252M	$3.397M
YoY Change	37.17%	54.61%	17.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.544M	-$5.236M	-$3.203M
YoY Change	46.78%	63.45%
Common Stock	$235.00	$235.00	$235.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.544M	-$5.235M	-$3.203M
YoY Change
Total Liabilities & Shareholders Equity	$15.81M	$15.45M	$22.02M
YoY Change	-30.33%	-29.81%	-72.35%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	$46.54K	$81.13K	$112.2K
YoY Change	171.65%	-27.68%	-635.79%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$94.49K	-$207.3K	-$210.1K
YoY Change	-69.32%	-1.33%	-395.39%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$150.0K	$8.332M	$57.95M
YoY Change	-58.33%	-85.62%	-173.56%
Cash From Investing Activities	-$150.0K	$8.332M	$57.95M
YoY Change	-58.33%	-85.62%	-173.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	243.1K	-8.126M	-57.95M
YoY Change	-63.17%	-85.98%	-172.93%
NET CHANGE
Cash From Operating Activities	-94.49K	-207.3K	-210.1K
Cash From Investing Activities	-150.0K	8.332M	57.95M
Cash From Financing Activities	243.1K	-8.126M	-57.95M
Net Change In Cash	-1.430K	-1.340K	-210.1K
YoY Change	-82.01%	-99.36%	-127.77%
FREE CASH FLOW
Cash From Operating Activities	-$94.49K	-$207.3K	-$210.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001865468
CY2023Q2	KACL	Cash Held In Trust Account Noncurrent CashHeldInTrustAccountNoncurrent		usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q4	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41155
	dei	Entity Registrant Name EntityRegistrantName	Kairous Acquisition Corp. Limited
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Level 39 Marina Bay Financial Centre Tower 2
	dei	Entity Address Address Line2 EntityAddressAddressLine2	10 Marina Boulevard
	dei	Entity Address City Or Town EntityAddressCityOrTown	City Singapore
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	018983
	dei	Entity Address Country EntityAddressCountry	SG
	dei	City Area Code CityAreaCode	+662
	dei	Local Phone Number LocalPhoneNumber	255-6851340
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3683906	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1809	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39359	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14853	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	72810	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	16662	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	112169	usd
CY2023Q4	KACL	Cash Held In Trust Account Noncurrent CashHeldInTrustAccountNoncurrent	15437738	usd
CY2023Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	22802239	usd
CY2023Q4	us-gaap	Assets Assets	15454400	usd
CY2023Q2	us-gaap	Assets Assets	22914408	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	244013	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	123638	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1490000	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	840000	usd
CY2023Q4	KACL	Working Capital Loans Sponsor WorkingCapitalLoansSponsor	788000	usd
CY2023Q2	KACL	Working Capital Loans Sponsor WorkingCapitalLoansSponsor	420000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2522013	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1383638	usd
CY2023Q4	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	2730000	usd
CY2023Q2	KACL	Deferred Underwriting Commission Non Current DeferredUnderwritingCommissionNonCurrent	2730000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5252013	usd
CY2023Q2	us-gaap	Liabilities Liabilities	4113638	usd
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1337763	shares
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2089816	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.50
CY2023Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.91
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	15437738	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	22802239	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2023Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	1337763	shares
CY2023Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares	2089816	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	235	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	235	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5235586	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4001704	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5235351	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4001469	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15454400	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22914408	usd
CY2023Q4	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	15000	usd
CY2022Q4	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	15000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	211399	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	398891	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	553883	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	580199	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	226399	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	413891	usd
	us-gaap	Operating Expenses OperatingExpenses	583883	usd
	us-gaap	Operating Expenses OperatingExpenses	610199	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-226399	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-413891	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-583883	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-610199	usd
CY2022Q4	us-gaap	Interest Income Other InterestIncomeOther	8	usd
	us-gaap	Interest Income Other InterestIncomeOther	1	usd
	us-gaap	Interest Income Other InterestIncomeOther	19	usd
CY2023Q4	us-gaap	Investment Income Net InvestmentIncomeNet	307533	usd
CY2022Q4	us-gaap	Investment Income Net InvestmentIncomeNet	526077	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	607201	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	881658	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	307533	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	526085	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	607202	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	881677	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	81134	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	112194	usd
	us-gaap	Net Income Loss NetIncomeLoss	23319	usd
	us-gaap	Net Income Loss NetIncomeLoss	271478	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4296993	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4296993	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8408261	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8408261	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4366476	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4366476	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9277202	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9277202	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4001469	usd
CY2023Q3	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-659668	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-57815	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-4718952	usd
CY2023Q4	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-597533	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	81134	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	81134	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5235351	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2232806	usd
CY2022Q3	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-355581	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2429103	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2429103	usd
CY2022Q4	KACL	Temporary Equity Remeasurement To Redemption Value Adjustment TemporaryEquityRemeasurementToRedemptionValueAdjustment	-886077	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3202986	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3202986	usd
	us-gaap	Net Income Loss NetIncomeLoss	23319	usd
	us-gaap	Net Income Loss NetIncomeLoss	271478	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	607201	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	881658	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-57957	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49998	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-22765	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	120375	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	185724	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-405550	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-351693	usd
	KACL	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	650000	usd
	KACL	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	360000	usd
	KACL	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	8621702	usd
	KACL	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	58312401	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7971702	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	57952401	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8621702	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	58312401	usd
	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	650000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	368000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	360000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7603702	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57952401	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37550	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-351693	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39359	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	482965	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1809	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	131272	usd
	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue	1257201	usd
	KACL	Current Period Remeasurement Adjustment Of Ordinary Shares To Redemption Value CurrentPeriodRemeasurementAdjustmentOfOrdinarySharesToRedemptionValue	1241658	usd
CY2021Q4	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	4843252	usd
CY2021Q4	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1559900	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2730000	usd
CY2021Q4	KACL	Other Offering Costs OtherOfferingCosts	553352	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2730000	usd
	KACL	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
	KACL	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	0.50	pure
	KACL	Threshold Percentage Of Public Shares Subject To Redemption Without Companys Prior Written Consent ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanysPriorWrittenConsent	0.15	pure
	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
	KACL	Redemption Period Upon Closure RedemptionPeriodUponClosure	P12M
	KACL	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
	KACL	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	50000	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	50000	usd
CY2023Q4	KACL	Working Capital Deficit WorkingCapitalDeficit	2505351	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1809	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zTlEMHZNOGq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zqK2dM0gesQ1">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1809	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39359	usd
CY2023Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	22800000	usd
CY2023Q4	KACL	Cash Held In Trust Account CashHeldInTrustAccount	15400000	usd
	KACL	Offering Costs Associated With Initial Public Offering OfferingCostsAssociatedWithInitialPublicOffering	<p id="xdx_845_ecustom--OfferingCostsAssociatedWithInitialPublicOffering_zmMibZjTNI5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zmXjJCPv7bP2">Offering Costs associated with the Initial Public Offering</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, <i>“Expenses of Offering.”</i> Offering costs of $<span id="xdx_90D_eus-gaap--OperatingCostsAndExpenses_c20230701__20231231_z3d0DLJhBo74" title="Transaction costs">894,582</span> consisted principally of costs incurred in connection with preparation for the Initial Public Offering. These offering costs, together with the underwriter fees of $<span id="xdx_902_ecustom--UnderwriterFee_c20230701__20231231_zSwFwdHLmHs8" title="Underwriter fees">4,289,900</span> (or $<span id="xdx_90F_eus-gaap--PaymentsForUnderwritingExpense_c20230701__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zoTzgqb3kEBk" title="Underwriting fees">1,559,900</span> paid in cash upon the closing of the Initial Public Offering and a deferred fee of $<span id="xdx_905_eus-gaap--OtherUnderwritingExpense_c20230701__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--DeferredUnderwritingCommissionsMember_z35vMxETyGwg" title="Deferred underwriter fees">2,730,000</span>), were charged to stockholders’ equity upon completion of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	894582	usd
	KACL	Underwriter Fee UnderwriterFee	4289900	usd
CY2023Q4	KACL	Working Capital Loans Sponsor WorkingCapitalLoansSponsor	788000	usd
CY2023Q4	KACL	Extension Loans ExtensionLoans	1490000	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	5710184	shares
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	58312401	usd
CY2023Q4	KACL	Temporary Equity Subject To Possible Redemption TemporaryEquitySubjectToPossibleRedemption	1337763	shares
CY2023Q2	KACL	Temporary Equity Subject To Possible Redemption TemporaryEquitySubjectToPossibleRedemption	2089816	shares
CY2023Q4	KACL	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	15437738	usd
CY2023Q2	KACL	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	22802239	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	5710184	shares
	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	752053	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zdg8BVPOcpe9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zuWVxtlKqUZc">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20231231_ziwHW8LcUTK6" title="Cah FDIC insured amount">250,000</span>. The Company has not experienced losses on this account. The Company has not experienced any losses on the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Management Fee Expense ManagementFeeExpense	15000	usd
CY2022Q4	us-gaap	Management Fee Expense ManagementFeeExpense	15000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	30000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	30000	usd
CY2023Q4	KACL	Working Capital Loans Sponsor WorkingCapitalLoansSponsor	788000	usd
CY2023Q2	KACL	Working Capital Loans Sponsor WorkingCapitalLoansSponsor	420000	usd
CY2023Q4	KACL	Extension Loans ExtensionLoans	1490000	usd
CY2023Q2	KACL	Extension Loans ExtensionLoans	840000	usd
CY2023Q2	KACL	Business Combination Ordinary Price Per Share BusinessCombinationOrdinaryPricePerShare	10.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1125000	shares
	KACL	Deferred Purchase Fee DeferredPurchaseFee	100	usd
	KACL	Deferred Underwriting Fee DeferredUnderwritingFee	105000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	39000	shares
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	341230	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	2000000	usd
CY2022Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2730000	usd
CY2022Q4	us-gaap	Share Price SharePrice	10.00
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2346143	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2346143	shares
CY2023Q4	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	1337763	shares
CY2023Q2	KACL	Shares Subject To Mandatory Redemption Settlement Terms Shares SharesSubjectToMandatoryRedemptionSettlementTermsShares	2089816	shares
CY2023	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	5710184	shares
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	58312401	usd
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	752053	shares
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	8621702	usd
	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Description SharesSubjectToMandatoryRedemptionSettlementTermsDescription	if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders
	KACL	Shares Issuable Upon Conversion As Percentage On Shares Outstanding After Conversion SharesIssuableUponConversionAsPercentageOnSharesOutstandingAfterConversion	0.098	pure

Files In Submission

Name	View Source	Status
0001493152-24-007254-index-headers.html	Edgar Link	pending
0001493152-24-007254-index.html	Edgar Link	pending
0001493152-24-007254.txt	Edgar Link	pending
0001493152-24-007254-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kacl-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kacl-20231231_cal.xml	Edgar Link	unprocessable
kacl-20231231_def.xml	Edgar Link	unprocessable
kacl-20231231_lab.xml	Edgar Link	unprocessable
kacl-20231231_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl

2024 Q1 Form 10-Q Financial Statement

#000149315224007254 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL Kairous Acquisition Corp. Ltd Stock $kacl

2024 Q1 Form 10-Q Financial Statement

#000149315224007254 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KACL
Kairous Acquisition Corp. Ltd Stock $kacl